Pierre Beaurang, Ph.D.
Chief Business Officer
Pierre Beaurang, Ph.D. serves as our Chief Business Officer. Prior to joining Nurix, Dr. Beaurang was part of the founding team of Five Prime Therapeutics where he contributed to the conceptualization and creation of the company. Dr. Beaurang then held roles of increasing responsibility and negotiated a number of major collaborations with global pharmaceutical firms, including with GlaxoSmithKline, UCB and Bristol Myers Squibb, helping secure an aggregate $270 million in near term revenues and more than $2.4 billion in potential milestone payments. Dr. Beaurang holds a Ph.D. in molecular and cell biology from the University of California, Berkeley and conducted postdoctoral research at the University of California, San Francisco. He holds a B.A. and a M.A. in biology and biotechnology, respectively, from Boston University.